BACKGROUND: Depression is prevalent during antenatal and postnatal stages of pregnancy. The effect of depression can be seen in complications during and after pregnancy, fetal growth retardation, abortions and preterm births. The literature abounds on postpartum depression (PD) while few studies are on antepartum depression (AD).
AIM: The systematic review aims to compute the prevalence of AD from published articles.
MATERIAL AND METHODS: The published articles (26) used in this review were obtained from the search of the search keywords “Depressive conditions in pregnancy AND trimesters”. All the articles were considered irrespective of language and their citation status as of the time of the query. Only articles that presented the prevalence mean and sample size were included. Articles on questionnaires filled by nonpregnant women and men were excluded. Articles that presented the prevalence of depression for the postpartum period only were excluded but were included if they addressed depression at both postpartum and trimester(s) of pregnancy. P-value of less than or equal to 0.05 was considered significant.
RESULTS: Analysis of the 26 articles showed that 4,303 subjects tested positive for depression in a sample of 28,248 pregnant mothers, giving the prevalence rate as 15%. Confounding was removed, and the sample size was adjusted to be 25,771 and 4,223 were screened to have depressive symptoms, thereby giving a new prevalence rate as 16.4%. It was also revealed that AD is most prevalent in the last trimester of pregnancy and least in the second trimester. Pregnancy duration and PD are not correlated with AD. This implies that AD can be observed in any period of the pregnancy and cannot predict the incidence of PD.
CONCLUSION: Efforts must be intensified to monitor pregnant women during the third trimester to reduce the incidence of maternal depression during pregnancy, thereby reducing the prevalence.
A B S T R A C TA three parameter probability model, the so called Weibull-exponential distribution was proposed using the Weibull Generalized family of distributions. Some important models in the literature were found to be sub models of the new model. Explicit expressions for some of its basic mathematical properties like moments, moment generating function, reliability analysis, limiting behavior and order statistics were derived. The method of maximum likelihood estimation was proposed in estimating its parameters and real life applications were provided to illustrate its flexibility and potentiality over the exponential distribution.
This article introduces a two-parameter probability model which represents another generalization of the Inverse Exponential distribution by using the quadratic rank transmuted map. The proposed model is named Transmuted Inverse Exponential (TIE) distribution and its statistical properties are systematically studied. We provide explicit expressions for its moments, moment generating function, quantile function, reliability function and hazard function. We estimate the parameters of the TIE distribution using the method of maximum likelihood estimation (MLE). The hazard function of the model has an inverted bathtub shape and we propose the usefulness of the TIE distribution in modeling breast cancer and bladder cancer data sets.
In this article, a random number of datasets was generated from random samples of used GSM (Global Systems for Mobile Communications) recharge cards. Statistical analyses were performed to refine the raw data to random number datasets arranged in table. A detailed description of the method and relevant tests of randomness were also discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.